Clinical trial / 2007
Enteric-coated peppermint oil for 4 weeks significantly improved symptoms in patients with irritable bowel syndrome.
Fifty-seven patients with irritable bowel syndrome were randomly assigned to receive enteric-coated peppermint oil (two capsules twice daily) or placebo for 4 weeks, with symptoms assessed at baseline (T0), week 4 (T4), and 4 weeks post-therapy (T8). At T4, 75% of the peppermint oil group achieved a >50% reduction in baseline total IBS symptoms score compared with 38% in the placebo group (P<0.009). The total symptoms score dropped significantly in the peppermint oil group from 2.19+/-0.13 at T0 to 1.07+/-0.10 at T4 and 1.60+/-0.10 at T8 (P<0.01 vs T0), whereas no change occurred with placebo.
- Study type
- Prospective double-blind placebo-controlled randomized trial
- Who was studied
- 57 patients with irritable bowel syndrome (Rome II criteria) with SIBO, lactose intolerance, and celiac disease excluded
- What was measured
- Total irritable bowel syndrome symptoms score and individual symptom intensity and frequency
THE PAPER
Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Dig Liver Dis, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.